Insider Shareholders with Direct Ownership of Lumos Pharma, Inc. (LUMO)
This section provides a comprehensive overview of the insiders with direct ownership of Lumos Pharma, Inc. (LUMO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
LUMOS PHARMA, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Richard J Hawkins
Chief Executive Officer |
15,829 | 7,311 | 753,093 $3.25 Million | 11 |
Apr 01, 2024
Reduced 0.2%
|
|
Pisit Duke Pitukcheewanont
Chief Medical Officer |
6,000 | 594 | 16,836 $72,731 | 3 |
Jul 01, 2024
Reduced 1.6%
|
|
Joseph S Mc Cracken
Director |
15,012 | 0 | 15,721 $67,914 | 4 |
Nov 16, 2022
Added 20.28%
|
|
John C. Mc Kew
Chief Scientific Officer |
26,578 | 29,718 | 12,653 $54,660 | 25 |
Aug 06, 2024
Reduced 21.21%
|
|
Lori D Lawley
Chief Financial Officer |
7,619 | 2,177 | 12,284 $53,066 | 15 |
Aug 01, 2024
Reduced 1.83%
|
|
Carl W. Langren
Chief Financial Officer |
939 | 683 | 11,494 $49,654 | 2 |
Apr 01, 2021
Reduced 5.61%
|
|
Eugene P. Kennedy
Chief Medical Officer |
939 | 0 | 11,423 $49,347 | 1 |
Feb 01, 2021
Added 7.6%
|
|
Thomas A. Raffin
Director |
1,517 | 0 | 9,406 $40,633 | 2 |
Aug 25, 2022
Added 10.89%
|
|
David B Karpf
Chief Medical Officer |
1,400 | 606 | 8,294 $35,830 | 4 |
Feb 01, 2023
Reduced 0.43%
|
|
Aaron Schuchart
Chief Business Officer |
5,000 | 358 | 6,679 $28,853 | 8 |
Apr 01, 2024
Added 13.02%
|
|
Bradley J Powers
General Counsel |
3,569 | 1,817 | 6,307 $27,246 | 11 |
Apr 01, 2024
Reduced 5.14%
|
|
Lota S. Zoth
Director |
367 | 0 | 2,187 $9,447 | 1 |
May 20, 2021
Added 14.37%
|
|
An Van Es Johansson
Director |
367 | 0 | 1,100 $4,752 | 1 |
May 20, 2021
Added 25.02%
|
|
Kevin M. Lalande
Director |
367 | 0 | 1,076 $4,648 | 1 |
May 20, 2021
Added 25.43%
|
|
Chad Allen Johnson
Director |
367 | 0 | 1,076 $4,648 | 1 |
May 20, 2021
Added 25.43%
|